Search


OMass Therapeutics CEO Ros Deegan on the company's "whole ecosystem" approach to drug discovery
She describes OMass' platform and rare disease focus.
May 1, 2024
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.